1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Abdominal Obesity-Pipeline Insights, 2016

Abdominal Obesity-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Abdominal Obesity-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Abdominal Obesity. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Abdominal Obesity. DelveInsight’s Report also assesses the Abdominal Obesity therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Abdominal Obesity
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Abdominal Obesity pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Abdominal Obesity and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Abdominal Obesity-Pipeline Insights, 2016

Illustrative Table of contents

- Abdominal Obesity Overview
- Abdominal Obesity Pipeline Therapeutics
- Abdominal Obesity Therapeutics under Development by Companies
- Abdominal Obesity Filed and Phase III Products
- Comparative Analysis
- Abdominal Obesity Phase II Products
- Comparative Analysis
- Abdominal Obesity Phase I and IND Filed Products
- Comparative Analysis
- Abdominal Obesity Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Abdominal Obesity - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Abdominal Obesity - Discontinued Products
- Abdominal Obesity - Dormant Products
- Companies Involved in Therapeutics Development for Abdominal Obesity
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Abdominal Obesity, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Abdominal Obesity Assessment by Monotherapy Products
- Abdominal Obesity Assessment by Combination Products
- Abdominal Obesity Assessment by Route of Administration
- Abdominal Obesity Assessment by Stage and Route of Administration
- Abdominal Obesity Assessment by Molecule Type
- Abdominal Obesity Assessment by Stage and Molecule Type
- Abdominal Obesity Therapeutics - Discontinued Products
- Abdominal Obesity Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Abdominal Obesity, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Abdominal Obesity Assessment by Monotherapy Products
- Abdominal Obesity Assessment by Combination Products
- Abdominal Obesity Assessment by Route of Administration
- Abdominal Obesity Assessment by Stage and Route of Administration
- Abdominal Obesity Assessment by Molecule Type
- Abdominal Obesity Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Obesity Treatment Market Size & Forecast, By Drugs, By Surgery & Devices And Trend Analysis To 2024

Obesity Treatment Market Size & Forecast, By Drugs, By Surgery & Devices And Trend Analysis To 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The global obesity treatment market is expected to reach USD 15.6 billion by 2024, according to a new report by Grand View Research, Inc. Upward trend in sedentary lifestyles, physical inactivity, and ...

Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021

Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021

  • $ 2995
  • Industry report
  • October 2016
  • by Beige Market Intelligence

The global intragastric balloons market is expected to grow at a CAGR of more than 7.01% till 2021. Global Intragastric Balloons Market - Strategic Assessment and Forecast till 2021 market research report ...

Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Obesity-api Insights, 2016

November 2016 $ 1250

Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Chronic Pain Statistics in Canada and the US

  • December 2016
    15 pages
  • Chronic Pain  

  • Canada  

    United States  

View report >

Diabetes Statistics in Australia

  • December 2016
    4 pages
  • Diabetes  

  • Australia  

View report >

Related Market Segments :

Obesity

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.